The Utility of PET/CT in Erlotinib treatment for Non-Small Cell cancer

UMIN ID: UMIN000002044

Registered date:08/06/2009

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Non-small cell lung cancer
• Date of first enrollment: 2009/06/01
• Target sample size: 20
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): PET/CT 2 days after erlotinib administration

Outcome(s)

• Primary Outcome: Relationship between uptake of FDG 2 days after the erlotinib administration and tumor size on CT
• Secondary Outcome: OS, PFS

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1)History of radiation therapy for primary site 2)Severe infection 3)Bowel obstruction 4)Interstitioal pneumonia or lung fibrosis 5)History of any thoracic radiation therapy 6)Active concomitant malignancy 7)Sever heart disease 8)No regulatory condition because of psychological disease 9)Pregnant women or somen willing child-bearing 10)inadequate condition siagnosed by primary physician

Related Information

• Primary Sponsor: Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine
• Source(s) of Monetary Support: none